diagnostic
No description yet: the sentence for this tag has not been written. 7 records carry it: 7 drugs.
7 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
5-Aminolevulinic acid (oral, for glioma surgery) Gleolan / Gliolan A drink taken before brain surgery that makes high-grade glioma glow under blue light, letting surgeons remove more tumour safely. | Approved2007🇺🇸🇪🇺🇬🇧🇯🇵+1 | Glioma & glioblastoma | none | ||
Fluciclovine F-18 Axumin Fluciclovine F-18 was the first PET tracer approved for finding recurrent prostate cancer after treatment (2016), and has been largely superseded since 2020 by PSMA PET. | Approved2016🇺🇸🇪🇺🇬🇧🇯🇵 | Prostate cancer, Glioma & glioblastoma | none | ||
Fluoroestradiol F-18 (FES PET) Cerianna A PET scan that shows which breast cancer deposits still have oestrogen receptors, helping decide whether hormone therapy will work when biopsy is impractical. | Approved2020🇺🇸 | HR-positive / HER2-negative breast cancer | none | ||
Gallium-68 DOTATATE (and Cu-64 DOTATATE) Netspot / Detectnet The PET scan for neuroendocrine tumours that finds far more disease than older scans and confirms eligibility for lutetium radioligand therapy (the theranostic pair). | Approved2016🇺🇸🇪🇺🇬🇧 | Neuroendocrine tumours, Small intestinal neuroendocrine tumours, Pancreatic neuroendocrine tumours | none | ||
Pafolacianine Cytalux An injected dye that makes ovarian and lung cancer deposits glow during surgery so surgeons can find lesions they would otherwise miss. | Approved2021🇺🇸 | Ovarian cancer, Non-small-cell lung cancer | none | ||
Pegulicianine Lumisight A cavity-imaging dye used during breast lumpectomy to spot leftover tumour before the operation ends, reducing second surgeries. | Approved2024🇺🇸 | HR-positive / HER2-negative breast cancer, Triple-negative breast cancer, HER2-positive breast cancer | none | ||
Technetium-99m tilmanocept Lymphoseek The purpose-built tracer for sentinel lymph node mapping in breast cancer, melanoma and oral cancer, replacing off-label sulfur colloid. | Approved2013🇺🇸🇬🇧 | HR-positive / HER2-negative breast cancer, Melanoma, Head and neck squamous cell carcinoma | none |